This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Iglehart, J. K. Search for Related Content PubMed Articles by Iglehart, J. K.

From the Editor

America’s Love Affair With Medical Innovation

Rising health care costs are once again causing an up-roar, and pharmaceuticals are in the crosshairs. As private health plans demand double-digit increases in their insurance premiums, they are identifying the soaring cost of prescription drugs as the major culprit. But drug prices are only a part of a more complex equation, which also involves providers’ growing muscle to negotiate better deals with health plans—a derivative of the consumer rebellion against tightly managed care—and society’s enchantment with all forms of medical innovation. If past is prologue, the preference for ever more technology will trump rising costs at almost every turn, . . . [Full Text of this Article]

John K. Iglehart

Founding Editor

                      What's this?